Deciding by Faces, Not Just Numbers
Let me record my final check when a management decision hangs in the balance. I examine the numbers, of course — market size, margins, risk; management without numbers is gambling. But when the numbers are all in and I still waver, the last thing I look at is faces. If we do this business, whose face will smile?
Employees', their families', customers', partners'. Ventures where a specific someone's smile comes to mind usually grow, even against tough numbers. And there are ventures with splendid numbers where no smile surfaces — profitable-sounding, yet unable to explain whom they make happy.
Those we decline, however good the figures: experience says hearts break midway, because numbers contain no fuel for the hardest stretches. Beyond the trillion I see faces, not figures — this is not poetry but practice: whether a face comes to mind is the most practical test of whether you can see a business through.
Whose face rises from your work today?
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.